Share capital and reserves (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share capital and reserves |
|
| Schedule of weighted average number of shares outstanding |
|
|
|
|
|
|
|
|
|
Year ended |
|
|
December 31, |
|
December 31, |
|
December 31, |
|
|
2025 |
|
2024 |
|
2023 |
Basic weighted average shares outstanding |
|
4,734,633 |
|
2,878,514 |
|
1,981,734 |
Effect of outstanding securities |
|
— |
|
— |
|
— |
Diluted weighted average shares outstanding |
|
4,734,633 |
|
2,878,514 |
|
1,981,734 |
|
| Summary of changes in warrants |
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
Number of |
|
Average |
|
|
|
Warrants |
|
Exercise price |
|
Balance, December 31, 2023 and 2022 |
|
1,125,210 |
|
$ |
22.31 |
|
Granted – February 9, 2024 |
|
824,767 |
|
|
3.13 |
(1) |
Granted – February 23, 2024 |
|
74,950 |
|
|
3.13 |
(1) |
Granted – October 18, 2024 |
|
810,810 |
|
|
2.18 |
|
Exercised |
|
(5,000) |
|
|
3.13 |
(1) |
Balance, December 31, 2024 |
|
2,830,737 |
|
$ |
3.60 |
|
Granted – July 21, 2025 |
|
1,267,123 |
|
|
1.20 |
|
Granted – August 8, 2025 |
|
156,849 |
|
|
1.20 |
|
Balance, December 31, 2025 |
|
4,254,709 |
|
$ |
2.82 |
|
(1) Exercise price of CAD $4.50.
|
| Schedule of information on warrants outstanding |
The following table summarizes information on warrants outstanding at December 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining |
|
|
Number |
|
|
|
Contractual |
Exercise Price |
|
Outstanding |
|
Expiry date |
|
Life |
$5.00 |
|
198,333 |
(1) |
February 9, 2026 |
|
0.11 years |
$5.00 |
|
270,211 |
|
October 15, 2026 |
|
0.79 years |
$5.00 |
|
101,111 |
|
October 15, 2026 |
|
0.79 years |
$5.00 |
|
555,555 |
|
October 7, 2027 |
|
1.77 years |
CAD $4.50 |
|
819,767 |
(1) |
February 9, 2026 |
|
0.11 years |
CAD $4.50 |
|
74,950 |
(1) |
February 23, 2026 |
|
0.15 years |
$2.18 |
|
810,810 |
|
October 18, 2029 |
|
3.80 years |
$1.20 |
|
1,267,123 |
|
July 21, 2030 |
|
4.56 years |
$1.20 |
|
156,849 |
|
August 8, 2030 |
|
4.61 years |
Total |
|
4,254,709 |
|
|
|
2.58 years |
(1) Expired unexercised subsequent to December 31, 2025.
|
| Schedule of the changes in pre-funded warrants |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Number of |
|
Average |
|
|
Warrants |
|
Exercise price |
Balance, December 31, 2022 |
|
328,777 |
|
$ |
0.0009 |
Exercised |
|
(328,777) |
|
|
0.0009 |
Balance, December 31, 2023 |
|
— |
|
|
— |
Granted – October 18, 2024 |
|
490,810 |
|
|
0.00001 |
Exercised |
|
(257,810) |
|
|
0.00001 |
Balance, December 31, 2024 |
|
233,000 |
|
$ |
0.00001 |
Granted – October 23, 2025 |
|
1,177,530 |
|
|
0.00001 |
Exercised |
|
(1,410,530) |
|
|
0.00001 |
Balance, December 31, 2025 |
|
— |
|
|
— |
|
| Schedule of changes in finders' warrants |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Number of |
|
Average |
|
|
Warrants |
|
Exercise price |
Balance, December 31, 2024, 2023 and 2022 |
|
50,298 |
|
$ |
23.57 |
Granted – July 21, 2025 |
|
16,800 |
|
|
1.20 |
Granted – October 23, 2025 |
|
87,500 |
|
|
0.69 |
Balance, December 31, 2025 |
|
154,598 |
|
$ |
8.25 |
Exercisable, December 31, 2025 |
|
67,098 |
|
$ |
18.11 |
|
| Schedule of information on finders' warrants outstanding |
The following table summarizes information on finders’ and underwriters’ warrants outstanding at December 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining |
|
|
Number |
|
|
|
Contractual |
Exercise Price |
|
Outstanding |
|
Expiry date |
|
Life |
CAD$42.30 |
|
6,377 |
(1) |
February 9, 2026 |
|
0.11 years |
$42.93 |
|
16,144 |
|
October 15, 2026 |
|
0.79 years |
$10.98 |
|
27,777 |
|
October 7, 2027 |
|
1.77 years |
$1.20 |
|
16,800 |
|
July 21, 2030 |
|
4.56 years |
$0.69 |
|
87,500 |
|
April 23, 2027 |
|
1.31 years |
Total |
|
154,598 |
|
|
|
1.64 years |
(1)Expired unexercised subsequent to December 31, 2025.
|
| Schedule of fair value of stock options granted was estimated on the date of grant using the Black-Scholes mode |
|
|
|
|
|
|
|
|
2024 |
|
2023 |
|
Dividend yield |
|
Nil |
|
Nil |
|
Annualized volatility |
|
100 |
% |
100 |
% |
Share price |
|
CAD $3.82 |
|
CAD $2.90 |
|
Risk-free interest rate |
|
3.47 |
% |
3.25 |
% |
Expected life |
|
5 years |
|
5 years |
|
|
| Schedule of the changes in stock options for the years |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Number of |
|
Average |
|
|
Options |
|
Exercise price (CAD) |
Balance, December 31, 2022 |
|
128,240 |
|
$ |
21.75 |
Granted – December 31, 2023 |
|
8,000 |
|
|
2.90 |
Expired |
|
(32,318) |
|
|
33.65 |
Balance, December 31, 2023 |
|
103,922 |
|
$ |
16.60 |
Granted – March 4, 2024 |
|
39,483 |
|
|
4.50 |
Granted – April 8, 2024 |
|
8,000 |
|
|
5.00 |
Granted – December 18, 2024 |
|
13,000 |
|
|
1.75 |
Expired |
|
(16,642) |
|
|
22.22 |
Balance, December 31, 2024 |
|
147,763 |
|
$ |
10.80 |
Expired |
|
(18,002) |
|
|
12.86 |
Balance, December 31, 2025 |
|
129,761 |
|
$ |
10.51 |
Vested and exercisable, December 31, 2025 |
|
109,596 |
|
$ |
11.86 |
|
| Schedule of information on stock options outstanding and contractual remaining life |
The following table summarizes information on stock options outstanding at December 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
Number |
|
Number |
|
|
|
Remaining |
Exercise Price (CAD$) |
|
Outstanding |
|
Exercisable |
|
Expiry Date |
|
Contractual Life |
16.92 |
|
2,366 |
|
2,366 |
|
May 12, 2026 |
|
0.36 years |
21.69 |
|
4,732 |
|
4,732 |
|
July 14, 2026 |
|
0.53 years |
22.86 |
|
7,262 |
|
7,262 |
|
December 21, 2026 |
|
0.97 years |
22.86 |
|
9,163 |
|
9,163 |
|
January 12, 2027 |
|
1.03 years |
14.40 |
|
37,200 |
|
37,200 |
|
June 6, 2027 |
|
1.43 years |
12.42 |
|
5,554 |
|
5,554 |
|
November 25, 2027 |
|
1.90 years |
2.90 |
|
8,000 |
|
8,000 |
|
December 31, 2028 |
|
3.00 years |
4.50 |
|
34,484 |
|
24,069 |
|
March 4, 2029 |
|
3.18 years |
5.00 |
|
8,000 |
|
8,000 |
|
April 8, 2029 |
|
3.27 years |
1.75 |
|
13,000 |
|
3,250 |
|
December 18, 2029 |
|
3.97 years |
|
|
129,761 |
|
109,596 |
|
|
|
|
|
| Schedule of significant unobservable inputs used in fair value measurement of liabilities |
|
|
|
|
|
|
2024 |
|
Dividend yield |
|
Nil |
|
Annualized volatility |
|
130-135 |
% |
Share price |
|
CAD$3.03 – CAD$3.40 |
|
Risk-free interest rate |
|
4.28% – 4.33 |
% |
Expected life |
|
2 years |
|
|
| Schedule of the derivative warrant liabilities |
|
|
|
|
Balance at December 31, 2022 |
|
$ |
3,854,403 |
Reclassified from reserves |
|
|
318,000 |
Fair value adjustment |
|
|
(3,641,403) |
Balance at December 31, 2023 |
|
$ |
531,000 |
Warrants issued February 9, 2024 |
|
|
1,102,000 |
Warrants issued February 23, 2024 |
|
|
103,000 |
Warrants exercised |
|
|
(5,244) |
Reclassified to reserves |
|
|
(123,651) |
Fair value adjustment |
|
|
(1,035,105) |
Balance at December 31, 2024 |
|
$ |
572,000 |
Fair value adjustment |
|
|
(564,000) |
Balance at December 31, 2025 |
|
$ |
8,000 |
|
| Schedule of significant on assumptions used in determining the fair value of the derivative warrant liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
December 31, |
|
December 31, |
|
|
|
2025 |
|
2024 |
|
2023 |
|
Share price |
|
$ |
0.56 |
|
$ |
1.13 |
|
$ |
2.31 |
|
Risk-free interest rate |
|
|
2.55 |
% |
|
2.92 |
% |
|
3.25%-3.91 |
% |
Dividend yield |
|
|
0 |
% |
|
0 |
% |
|
0 |
% |
Expected volatility |
|
|
78%-127 |
% |
|
94%-134 |
% |
|
100 |
% |
Remaining term (in years) |
|
|
0.1–1.8 |
|
|
1.1-2.8 |
|
|
2.1-3.8 |
|
|